relatlimab

Go or no go? Bristol’s Lag3 debut
EP Vantage
Fri, 02/25/22 - 10:21 am
Bristol Myers Squibb
relatlimab
FDA
AMX0035
Amylx
Bristol Myers details data for closely watched cancer immunotherapy
BioPharma Dive
Wed, 05/19/21 - 11:27 pm
ASCO 2021
immunotherapy
Bristol Myers Squibb
Opdivo
skin cancer
relatlimab
3 Promising Cancer Immunotherapies to Watch in 2018
Yahoo/Motley Fool
Fri, 12/22/17 - 09:46 am
cancer
immuno-oncology
Incyte
epacadostat
Bristol-Myers Squibb
relatlimab
Nektar
NKTR-214